| Peptide: | BPC-157 10 mg |
| Rehydrate with: | 200 ticks / 2 CC of bacteriostatic water |
| Doses: | 20 doses per vial |
| Dosage: | .5 mg 10 “ticks” on insulin needle Give near location of pain or injury (if possible). Use for pain as needed |
| Benefits | Accelerates healing of bones, muscles, ligaments, tendons, wounds, sprains, tears, cornea, and intestine. Accelerated healing after surgery. |
| Possible Side Effects: | Redness at injection site, short term lethargy, headache, flush, peripheral edema (at higher doses) |
| Peptide: | BPC-157 (10mg) / TB-500 (5 or 10mg) |
| Rehydrate with: | 200 ticks / 2 CC of bacteriostatic water |
| Doses: | 20 doses per vial |
| Dosage: | .5 mg of each peptide 10 “ticks” on insulin needle Give near the location of pain or injury Use for pain as needed |
| Benefits | Accelerates healing of bones, muscles, ligaments, tendons, wounds, sprains, tears, cornea, and intestine. Accelerated healing after surgery. |
| Possible Side Effects: | Redness at injection site, short term lethargy, headache, flush, peripheral edema (at higher doses) |
| Peptide: | BPC-157 (11mg) / TB-500 (11mg) |
| Rehydrate with: | 220 ticks / 2 CC of bacteriostatic water |
| Doses: | 22 doses per vial |
| Dosage: | .5 mg of each peptide 10 “ticks” on insulin needle Give near the location of pain or injury Use for pain as needed |
| Benefits | Accelerates healing of bones, muscles, ligaments, tendons, wounds, sprains, tears, cornea, and intestine. Accelerated healing after surgery. |
| Possible Side Effects: | Redness at injection site, short term lethargy, headache, flush, peripheral edema (at higher doses) |
Never used peptides before? Check out our video on how to do injections safely - scroll to the bottom of the page. https://www.vigeohealth.net/peptides
What is BPC-157?
BPC stands for Body Protecting Compound. It was discovered in, and isolated from, human gastric juice. Your own stomach makes it.
It accelerates healing across a wide range of tissue types: tendon-to-bone healing, damaged ligaments, torn or crushed muscle, and skin burns. People dealing with discomfort from muscle sprains, tears, and damage are the most common users.
It works by enhancing your body's own healing processes rather than overriding them. That distinction matters, and it is why the side effect profile is what it is.
What does BPC-157 actually repair?
- Soft tissue: sprains, strains, ligament tears
- Broken bones
- Tendons, including detached or disjoined Achilles tendon
- Muscle, including torn, crushed, or damaged tissue
- Brain
- Cornea
- Intestine and gut lining
- Skin burns, by increasing blood flow to damaged tissue
How does it work?
Five mechanisms, working together:
- Improves angiogenesis, the creation of new blood vessels in wounded and damaged areas, which improves blood flow to where repair is needed.
- Reduces the release of inflammatory mediators.
- Interacts with prostaglandin pathways.
- Modulates the release of nitric oxide.
- Up-regulates growth factors.
Better blood supply plus less inflammatory interference plus more growth signalling is why the effect shows up across so many different tissue types.
What about the gut, and EMF exposure?
This is where BPC-157 gets interesting alongside two other peptides.
BPC-157, KPV, and TB500 are arguably the best combination for EMF-induced leaky gut, leaky brain, and a dysfunctional gut-brain axis.
They divide the work:
| Peptide | Role |
|---|---|
| TB500 | Directly repairs EMF-induced tight junction dysfunction |
| BPC-157 | Maintains, protects, and repairs GI mucosal and blood-brain barrier integrity |
| KPV | Same protective role, working alongside BPC-157 |
The effect when used together is strongly synergistic. Each one alone does less than the three together.
What about cardiovascular effects?
Oral and systemic administration significantly improves varied cardiovascular issues by blocking many of the toxic effects of EMF exposure: immune dysfunction, mitochondrial dysfunction, excessive reactive oxygen species, and abnormal activation of voltage-gated calcium channels.
Improvements have been observed in heart failure, hypotension and hypertension, post-MI cardiac damage, arrhythmias including shortening of a long QT interval, and vascular damage.
Read that section with appropriate caution. These are observations from the research literature, not claims about what will happen to you. Cardiovascular conditions require a cardiologist, not a peptide protocol.
Side effects and warnings
Side effects: less than placebo when dosed correctly. That is an unusual profile and it is one reason BPC-157 is so widely used.
Elite athletes: BPC-157 is banned by WADA. If you compete in a tested sport, this will fail a test. Check the current prohibited list before anything else. This is your responsibility and the penalties are serious.
Sourcing and quality
Peptides sold outside compounding pharmacies are required to be labelled "Not For Human Consumption and For Research Use Only." They are the same product sold in compounding pharmacies, and should always be third-party tested for quality, purity, and content.
Ask your vendor for testing results. If results are not available for the specific batch you are buying, go to someone who can provide them.
VIGEO Health does not sell injectable peptides. Third-party vendors can be recommended on request: email dawn@vigeohealth.net.
Test your foundations first
No peptide can outperform a toxic, deficient, or overstressed system.
BPC-157 signals your body to build. Building consumes minerals: zinc for tissue repair, magnesium for the enzymes that do the work, copper for connective tissue. If those are depleted, or a heavy metal burden is competing for the same pathways, the signal arrives and the materials are not there.
See what the OligoScan measures
What this page does not tell you
- BPC-157 is not an approved medication. It is sold as a research compound, which means manufacture is not held to pharmaceutical standards.
- Most of the research is preclinical. Animal and in-vitro studies dominate. Human trial data is limited.
- Long-term safety data does not exist in the way it does for established medications.
- Nothing here treats disease. Cardiovascular, gastrointestinal, and orthopaedic conditions need proper medical evaluation.
- Injectable use belongs under medical supervision, not a coach and not a forum.
- Tell your physician what you are taking.
References and further reading
- Greenfield, Ben. How to Use BPC-157. bengreenfieldlife.com
- Literature on BPC-157 and tendon-to-bone healing.
- Research on angiogenesis and growth factor upregulation in soft tissue repair.
- VIGEO Health Medical Disclaimer
Related peptides
- TB500: dosing and tissue repair — the synergistic partner
- KPV: inflammation and gut lining — the third of the gut trio
- All peptides
Test what is actually going on first. Book an OligoScan
Questions and Answers
Q: How is BPC-157 dosed? A: One to two doses per day, continued until the injury has healed. A standard vial provides around 20 doses. The half-life is approximately four hours, which is why twice daily dosing is common. It does not need to be injected near the site of injury, because it acts systemically.
Q: What is BPC-157? A: BPC stands for Body Protecting Compound. It is a peptide discovered in and isolated from human gastric juice. It accelerates healing of soft tissue, tendons, ligaments, bone, brain, cornea, and intestine by enhancing the body's own repair processes rather than overriding them.
Q: Should you take BPC-157 orally or by injection? A: The route changes what it reaches. Taken orally it acts locally in the digestive tract, which suits stomach issues, leaky gut, IBS, gastrointestinal cramping, and Crohn's disease. Injected, it acts systemically throughout the body, which suits soft tissue injury, tendon and ligament repair, and bone healing.
Q: Does BPC-157 have side effects? A: Reported side effects are less than placebo when dosing is administered correctly. It is banned by WADA, so elite athletes competing in tested sports should not use it. It is sold as a research compound rather than an approved medication, and long-term human safety data is limited.